Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI.

Clinical and translational science·2026

Same author

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention.

Clinical pharmacology and therapeutics·2026

Same author

2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> Genotyping.

Journal of the American Heart Association·2026

Same author

Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y<sub>12</sub> Inhibitor Therapy.

JACC. Advances·2026

Same author

In-Hospital ST-Segment-Elevation Myocardial Infarction: Years Later, Still the Same?

Circulation. Cardiovascular interventions·2026

Same author

Interpretation of Discordance Between Non-Hyperemic Pressure Ratios and Fractional Flow Reserve: Potential Mechanisms and Clinical Implications.

Reviews in cardiovascular medicine·2025

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Mechanical thrombectomy options in complex percutaneous coronary interventions.

Robert V Kelly¹, Mauricio G Cohen, George A Stouffer

¹Division of Cardiology, University of North Carolina, Chapel Hill, NC 27517, USA. rkelly@med.unc.edu

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions

|November 7, 2006

Summary

Managing thrombus-containing lesions during percutaneous coronary interventions (PCI) presents challenges. This review explores pharmacological and mechanical strategies, including embolic protection devices, to improve outcomes in PCI.

Related Experiment Videos

Last Updated: Jul 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Area of Science:

Cardiology
Interventional Cardiology
Vascular Medicine

Background:

Percutaneous coronary interventions (PCI) in thrombus-containing lesions carry high risks of complications and poor long-term vessel patency.
Technical challenges include coronary no-reflow and distal embolization, necessitating advanced management strategies.

Purpose of the Study:

To examine current approaches for managing thrombotic lesions during PCI.
To review the evidence supporting various mechanical thrombectomy options for interventional cardiologists.

Main Methods:

Review of pharmacological strategies (e.g., glycoprotein IIbIIIa inhibitors).
Analysis of mechanical strategies, including embolic protection devices and thrombectomy catheters.
Evaluation of clinical outcomes associated with different interventions.

Main Results:

Pharmacological agents reduce thrombus propagation and improve coronary blood flow.
Mechanical devices aim to improve coronary blood flow and myocardial perfusion, with variable clinical outcome data.
Embolic protection devices show benefit in saphenous vein graft (SVG) PCI, but their role in native coronary arteries requires further investigation.

Conclusions:

Effective management of thrombotic lesions in PCI requires a combination of pharmacological and mechanical approaches.
Mechanical thrombectomy options offer potential benefits, but their clinical impact and optimal use, especially in native arteries, warrant further research.